Evrysdi (risdiplam for oral solution)

Evrysdi (risdiplam) is a survival of motor neuron 2 (SMN2) splicing modifier used to treat spinal muscular atrophy (SMA) in patients 2 months of age and older.

Evusheld (tixagevimab injection; cilgavimab injection, copackaged for intramuscular use)

Evusheld (tixagevimab co-packaged with cilgavimab) is a SARS-CoV-2 spike protein-directed attachment inhibitor indicated for the pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and pediatric individuals (12 years of age and older weighing at least 40 kg) who are not currently infected with SARS-CoV-2 and who have not had a known recent exposure to an individual infected with SARS-CoV-2 and who have moderate to severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments and may not mount an adequate immune response to COVID-19 vaccination or for whom vaccination with any available COVID-19 vaccine, according to the approved or authorized schedule, is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine(s) and/or COVID-19 vaccine component(s).

Evzio (naloxone hydrochloride auto-injector for injection)

Evzio (naloxone hydrochloride injection) is an opioid antagonist used for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Exalgo (hydromorphone hydrochloride extended release tablets)

Exelderm (sulconazole)

Exelon (rivastigmine tartrate)

Exelon (rivastigmine tartrate) is a reversible cholinesterase inhibitor used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease.

Exelon Patch (rivastigmine transdermal system)

Exelon Patch (rivastigmine transdermal system) is a reversible cholinesterase inhibitor used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease.

Exkivity (mobocertinib capsules)

Exkivity (mobocertinib) is a kinase inhibitor used to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.

Exservan (riluzole oral film)

Exservan (riluzole) is a benzothiazole class drug used to treat amyotrophic lateral sclerosis (ALS).

Extavia (interferon beta-1b kit)

Extavia (interferon beta-1b) Kit is made from human proteins and is used to treat relapsing multiple sclerosis (MS). Extavia will not cure MS, it will only decrease the frequency of relapse symptoms.